drugset / Trial / NCT00069706
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2003-07
- Primary completion
- 2003-10
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AL-12182 | Small molecule | 0.003 % | Other |
| Subject | AL-12182 | Small molecule | 0.01 % | Other |
| Subject | AL-12182 | Small molecule | 0.03 % | Other |
| Comparator | Latanoprost | Small molecule | 0.005 % | Other |